Literature DB >> 29648690

Incremental value of left atrial active function measured by speckle tracking echocardiography in patients with hypertrophic cardiomyopathy.

Kaori Fujimoto1, Katsuji Inoue1, Makoto Saito2, Haruhiko Higashi1, Tamami Kono1, Teruyoshi Uetani1, Jun Aono1, Takayuki Nagai1, Kazuhisa Nishimura1, Jun Suzuki1, Takafumi Okura1, Shuntaro Ikeda1, Satoshi Nakatani3, Jitsuo Higaki1.   

Abstract

PURPOSE: Hypertrophic cardiomyopathy (HCM) impairs left ventricular (LV) diastolic function leading to left atrial (LA) dilatation. Because Doppler echocardiography cannot accurately assess LV diastolic function in hearts with heterogeneous hypertrophy, assessment of LA function might be useful for risk stratification of patients with HCM. This study aimed to elucidate the impact of LA function on outcome in patients with patients.
METHODS: Seventy-six patients with HCM who underwent echocardiographic and cardiac magnetic resonance imaging were retrospectively enrolled. Twenty-six control subjects were also included. Using speckle tracking echocardiography, LA function was divided into active and passive strain indices based on the timing of the second positive peak of LA strain rate that occurred during LV systole.
RESULTS: Left atrial strain indices of active and passive function were significantly impaired concomitantly with increased LA volume index in HCM patients compared with controls. During follow-up (2.6 ± 1.7 years), 14 patients with HCM developed cardiac events (heart failure hospitalization or atrial fibrillation). The association of LA active strain with cardiac events was independent of and incremental to clinical and echocardiographic parameters (age, gender, E/e', LV global longitudinal strain, and LA volume index) in sequential models. Cardiac events were more frequent in HCM patients with LA active strain <20.3% than with active strain ≥20.3% (P = .01).
CONCLUSION: Loss of LA active function was associated with increased cardiac events in patients with HCM.
© 2018 Wiley Periodicals, Inc.

Entities:  

Keywords:  atrial fibrillation; heart failure; hypertrophic cardiomyopathy; strain

Mesh:

Year:  2018        PMID: 29648690     DOI: 10.1111/echo.13886

Source DB:  PubMed          Journal:  Echocardiography        ISSN: 0742-2822            Impact factor:   1.724


  5 in total

Review 1.  Evaluation of Hypertrophic Cardiomyopathy: Newer Echo and MRI Approaches.

Authors:  Manhal Habib; Sara Hoss; Harry Rakowski
Journal:  Curr Cardiol Rep       Date:  2019-06-26       Impact factor: 2.931

Review 2.  Contemporary narrative review on left atrial strain mechanics in echocardiography: cardiomyopathy, valvular heart disease and beyond.

Authors:  Vardhmaan Jain; Raktim Ghosh; Manasvi Gupta; Yoshihito Saijo; Agam Bansal; Medhat Farwati; Rachel Marcus; Allan Klein; Bo Xu
Journal:  Cardiovasc Diagn Ther       Date:  2021-06

3.  Right atrial function assessed by volume-derived values and speckle tracking echocardiography in patients with hypertrophic cardiomyopathy.

Authors:  Jun Huang; Chao Yang; Cai-Fang Ni; Zi-Ning Yan; Li Fan; Xiang-Ting Song
Journal:  BMC Cardiovasc Disord       Date:  2020-07-13       Impact factor: 2.298

4.  Prognostic significance of left atrial strain in sarcomere gene variant carriers without hypertrophic cardiomyopathy.

Authors:  Roy Huurman; Daniel J Bowen; Ferit O Mutluer; Bernardo Loff Barreto; Marjon A van Slegtenhorst; Judith M A Verhagen; Alexander Hirsch; Annemien E van den Bosch; Michelle Michels; Arend F L Schinkel
Journal:  Echocardiography       Date:  2022-08-17       Impact factor: 1.874

5.  Quantification of left atrial function in patients with non-obstructive hypertrophic cardiomyopathy by cardiovascular magnetic resonance feature tracking imaging: a feasibility and reproducibility study.

Authors:  Yingxia Yang; Gang Yin; Yong Jiang; Lei Song; Shihua Zhao; Minjie Lu
Journal:  J Cardiovasc Magn Reson       Date:  2020-01-02       Impact factor: 5.364

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.